AstraZeneca bolsters heart and kidney business with $1.8 billion deal with CinCor

AZN shares slip 1% on Monday Farxiga-baxdrostat combination could expand franchise – AZN exec Falling valuations of biotech companies could boost deal-making Jan 9 (Reuters) – AstraZeneca (AZN.L) said on Monday it has reached an agreement to buy U.S. drug developer CinCor Pharma Inc (CINC.O) for up to $1.8 billion to boost its stock of … Read more

Exclusive: US plans to send 100-mile strike weapon to Ukraine

WASHINGTON, Nov 28 (Reuters) – The Pentagon is considering a Boeing proposal to supply Ukraine with small, inexpensive precision bombs mounted on abundantly available rockets, allowing Kyiv to strike far behind Russian lines as the West is struggling to meet the demand for additional armaments. US and allied military stocks are dwindling and Ukraine faces … Read more

GSK’s oncology business suffers another blow with Zejula setback

News follows setback for GSK’s blood cancer drug Blenrep Shares fall nearly 5% in afternoon trading Nov 11 (Reuters) – Britain’s GSK said on Friday it would limit the use of its ovarian cancer drug Zejula in the United States as a second treatment option to ward off cancer in patients whose tumors carry certain … Read more

Exclusive: Europe prepares for mobile network outages

PARIS/STOCKHOLM/MILAN, Sept 29 (Reuters) – Once unthinkable, mobile phones could die out this winter in Europe if power cuts or energy rationing disrupt parts of mobile networks in the region. Russia’s decision to cut off gas supplies via Europe’s key supply route following the conflict in Ukraine has increased the risk of power shortages. In … Read more